BJSE:920367'
s FCF Margin % Range Over the Past 10 Years
Min: -36.57 Med: 10.88 Max: 47.66
Current: -36.57
During the past 10 years, the highest FCF Margin % of Jiangxi Xinganjiang Pharmaceutical Co was 47.66%. The lowest was -36.57%. And the median was 10.88%.
BJSE:920367's FCF Margin % is ranked worse than 87.87% of 956
companies
in the Drug Manufacturers industry
Industry Median: 2.48
vs BJSE:920367: -36.57
Jiangxi Xinganjiang Pharmaceutical Co FCF Margin % Related Terms
Jiangxi Xinganjiang Pharmaceutical Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co FCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Xinganjiang Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangxi Xinganjiang Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangxi Xinganjiang Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Jiangxi Xinganjiang Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a FCF Margin % of -41.30% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. According to the industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #840 out of 956 companies in the Drug Manufacturers industry, placing it in the top 87.9%.
Is Jiangxi Xinganjiang Pharmaceutical Co's FCF Margin % too high?
Jiangxi Xinganjiang Pharmaceutical Co's current FCF Margin % is -41.30%. Based on the distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #840 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #840 out of 956 companies for FCF Margin %. This places Jiangxi Xinganjiang Pharmaceutical Co in the lower half of its industry. The industry median FCF Margin % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Xinganjiang Pharmaceutical Co's current FCF Margin % is -41.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥12.19, compared to a current price of ¥22.42 — trading 83.9% above its estimated fair value. The current FCF Margin % is -41.30%. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current FCF Margin % is -41.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥22.42 is trading 83.9% above its estimated GF Value™ of ¥12.19.
GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for BJSE:920367:
FCF Margin %: -41.30%
GF Value™: ¥12.19 vs. price of ¥22.42 (83.9% above fair value)
No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangxi Xinganjiang Pharmaceutical Co Business Description
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
60GF Score
Get the complete analysis for BJSE:920367
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920367 has been successfully added to your 
